GEFITINIB

8919 reported adverse events

Drug classes: Kinase Inhibitor [EPC]

These side effects are most commonly reported by patients taking GEFITINIB:

# Side effect Count
0 MALIGNANT NEOPLASM PROGRESSION 1811
1 DRUG RESISTANCE 1246
2 DIARRHOEA 900
3 DEATH 753
4 RASH 638
5 DISEASE PROGRESSION 456
6 INTERSTITIAL LUNG DISEASE 419
7 NAUSEA 376
8 METASTASES TO CENTRAL NERVOUS SYSTEM 373
9 DYSPNOEA 331
See all common reactions for GEFITINIB

GEFITINIB is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 MITOCHONDRIAL ASPARTATE AMINOTRANSFERASE INCREASED 9 0.7500
1 PRIDE SYNDROME 8 0.4444
2 EGFR GENE MUTATION 128 0.3516
3 HER2 GENE AMPLIFICATION 3 0.2000
4 ACQUIRED GENE MUTATION 258 0.1998
5 MALIGNANT TRANSFORMATION 69 0.1586
6 SARCOMATOID CARCINOMA 6 0.1111
7 BRAF V600E MUTATION POSITIVE 4 0.0727
8 NON-SMALL CELL LUNG CANCER RECURRENT 18 0.0690
9 METASTASES TO MENINGES 117 0.0553
See all enriched reactions for GEFITINIB